- $1.37bn
- $1.56bn
- $707.60m
- 73
- 65
- 53
- 68
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 855 | 764 | 868 | 765 | 708 |
Cost of Revenue | |||||
Gross Profit | 330 | 274 | 360 | 309 | 272 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 774 | 735 | 752 | 1,180 | 657 |
Operating Profit | 81.2 | 29.2 | 116 | -415 | 51.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 66.3 | 11.3 | 105 | -418 | 45 |
Provision for Income Taxes | |||||
Net Income After Taxes | 49.7 | 2.9 | 150 | -430 | 72.4 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 49.1 | 6.6 | 150 | -430 | 72.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 49.1 | 6.6 | 150 | -430 | 72.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.58 | 0.172 | 1.62 | -1.06 | 0.811 |